Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-27

FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for Humulin R (insulin human) by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humulin R

Snippet

SUPPL AP for HUMULIN R (INSULIN HUMAN)